LuPSMA moves UpFront | first RCT data with Arun Azad and Michael Hofman

GU Cast | Urology Podcast

Innehåll tillhandahållet av Professor Declan Murphy & Dr Renu Eapen, Professor Declan Murphy, and Dr Renu Eapen. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Professor Declan Murphy & Dr Renu Eapen, Professor Declan Murphy, and Dr Renu Eapen eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

2M ago 34:38

MP3•Episod hem

A big day at ESMO in Barcelona today as our friend and colleague A/Professor Arun Azad presents the results of the UpFront PSMA trial for the first time. The data were revealed in the main prostate cancer session at ESMO and simultaneously published in Lancet Oncology. UpFront PSMA is a randomised controlled trial comparing ADT and docetaxel, with ADT + done + LuPSMA in men newly diagnosed high-volume mHSPC. This is a world-first readout of LuPSMA in a prospective randomised trial for mHSPC, and clearly shows a benefit. We dive into the details today with Arun, and another friend and colleague, Professor Michael Hofman, nuc med lead for UpFront PSMA.
This is a Themed Podcast supported by our Silver Partners, Novartis.
Even better on our YouTube channel
Full paper in Lancet Oncology here

159 episoder

#Science #Fitness #Medicine #Dr Renu Eapen #Professor Declan Murphy #Urology #Prostate Cancer #Kidney Cancer #Testis Cancer #Penile Cancer #Gu Oncology #Cancer #Podcasting Education #Professor Declan Murphy And Dr Renu Eapen